Role of Procalcitonin as a Prognostic Biomarker in Hospitalized COVID-19 Patients: A Comparative Analysis.

Biomark Insights · 2025 · PMC12084704 · PMID 40386243

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

We also noted an increasing trend in Dexamethasone use across the WHO groups, with WHO scale 8 and WHO scale 5 having the highest use of dexamethasone (76.7% and 76.3%, respectively; Supplemental Table 2 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.